PMDA — authorised 28 March 2022
- Marketing authorisation holder: Taiho Pharmaceutical Co., Ltd.
- Status: approved
🇯🇵 Akynzeo in Japan
PMDA authorised Akynzeo on 28 March 2022
Marketing authorisation
Akynzeo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Akynzeo approved in Japan?
Yes. PMDA authorised it on 28 March 2022.
Who is the marketing authorisation holder for Akynzeo in Japan?
Taiho Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.